Patents by Inventor David R. Cheng

David R. Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220282308
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of nucleic acids. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
    Type: Application
    Filed: September 9, 2020
    Publication date: September 8, 2022
    Inventors: David A. SCOTT, David R. CHENG, Winston X. YAN, Tia M. DITOMMASO
  • Publication number: 20220282283
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of nucleic acids. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
    Type: Application
    Filed: September 4, 2020
    Publication date: September 8, 2022
    Inventors: David A. Scott, David R. Cheng, Winston X. Yan, Tia M. Ditommaso
  • Publication number: 20220127603
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of a nucleic acid.
    Type: Application
    Filed: November 8, 2021
    Publication date: April 28, 2022
    Inventors: David R. CHENG, David A. SCOTT, Winston X. YAN, Shaorong CHONG
  • Publication number: 20220098579
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of nucleic acids such as DNA. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
    Type: Application
    Filed: October 8, 2021
    Publication date: March 31, 2022
    Inventors: Shaorong Chong, Winston X. Yan, David A. Scott, David R. Cheng, Pratyusha Hunnewell
  • Publication number: 20220049273
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR-Cas systems, components, and methods for targeted modification of nucleic acids such as DNA. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
    Type: Application
    Filed: February 28, 2020
    Publication date: February 17, 2022
    Inventors: David R. Cheng, David A. Scott, Winston X. Yan, Jason Carte, Elise Keston-Smith, Pratyusha Hunnewell, Shaorong Chong
  • Publication number: 20220033793
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of nucleic acids. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
    Type: Application
    Filed: October 19, 2021
    Publication date: February 3, 2022
    Inventors: David A. Scott, David R. Cheng, Winston X. Yan, Tia M. DiTommaso
  • Patent number: 11168322
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of a nucleic acid.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: November 9, 2021
    Assignee: Arbor Biotechnologies, Inc.
    Inventors: David R. Cheng, David A. Scott, Winston X. Yan, Shaorong Chong
  • Patent number: 11168324
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of nucleic acids such as DNA. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
    Type: Grant
    Filed: December 31, 2020
    Date of Patent: November 9, 2021
    Assignee: ARBOR BIOTECHNOLOGIES, INC.
    Inventors: Shaorong Chong, Winston X. Yan, David A. Scott, David R. Cheng, Pratyusha Hunnewell
  • Publication number: 20210301288
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR-Cas systems, components, and methods for targeted modification of nucleic acids such as DNA. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
    Type: Application
    Filed: December 28, 2018
    Publication date: September 30, 2021
    Applicants: ARBOR BIOTECHNOLOGIES, INC., ARBOR BIOTECHNOLOGIES, INC.
    Inventors: David R. Cheng, David A. Scott, Winston X. Yan
  • Publication number: 20210198664
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of DNA, RNA, and protein substrates. Each system includes one or more protein components and one or more nucleic acid components that together target DNA, RNA, or protein substrates.
    Type: Application
    Filed: May 16, 2019
    Publication date: July 1, 2021
    Inventors: David R. Cheng, David A. Scott, Winston X. Yan
  • Publication number: 20210139890
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of a nucleic acid.
    Type: Application
    Filed: July 2, 2018
    Publication date: May 13, 2021
    Inventors: David R. CHENG, David A. SCOTT, Winston X. YAN, Shaorong CHONG
  • Publication number: 20210123047
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of nucleic acids such as DNA. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
    Type: Application
    Filed: December 31, 2020
    Publication date: April 29, 2021
    Inventors: Shaorong Chong, Winston X. Yan, David A. Scott, David R. Cheng, Pratyusha Hunnewell
  • Publication number: 20200407715
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of nucleic acids such as DNA. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
    Type: Application
    Filed: September 14, 2020
    Publication date: December 31, 2020
    Inventors: Shaorong Chong, Winston X. Yan, David A. Scott, David R. Cheng, Pratyusha Hunnewell
  • Publication number: 20200407716
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of nucleic acids such as DNA. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
    Type: Application
    Filed: September 14, 2020
    Publication date: December 31, 2020
    Inventors: Shaorong Chong, Winston X. Yan, David A. Scott, David R. Cheng, Pratyusha Hunnewell
  • Patent number: 10808245
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of nucleic acids such as DNA. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: October 20, 2020
    Assignee: ARBOR BIOTECHNOLOGIES, INC.
    Inventors: Shaorong Chong, Winston X. Yan, David A. Scott, David R. Cheng, Pratyusha Hunnewell
  • Publication number: 20200299659
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered Type III-E CRISPR-Cas systems, components, and methods for targeted modification of DNA, RNA, and protein substrates. Each system includes one or more protein components and one or more nucleic acid components that together target DNA, RNA, or protein substrates.
    Type: Application
    Filed: April 29, 2020
    Publication date: September 24, 2020
    Inventors: David R. Cheng, David A. Scott, Winston X. Yan
  • Publication number: 20200291395
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, enginceled CRISPR systems, components, and methods for targeted modification of DNA, RNA, and protein substrates. Each system includes one or more protein components and one or more nucleic acid components that together target DNA, RNA, or protein substrates.
    Type: Application
    Filed: November 2, 2018
    Publication date: September 17, 2020
    Inventors: David A. SCOTT, David R. CHENG, Winston X. YAN
  • Publication number: 20200255829
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of DNA, RNA, and protein substrates. Each system includes one or more protein components and one or more nucleic acid components that together target DNA, RNA, or protein substrates.
    Type: Application
    Filed: November 2, 2018
    Publication date: August 13, 2020
    Inventors: David A. SCOTT, David R. CHENG, Winston X. YAN
  • Publication number: 20200255830
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of DNA, RNA, and protein substrates. Each system includes one or more protein components and one or more nucleic acid components that together target DNA, RNA, or protein substrates.
    Type: Application
    Filed: November 2, 2018
    Publication date: August 13, 2020
    Inventors: David A. SCOTT, David R. Cheng, Winston X. YAN
  • Publication number: 20200063126
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of nucleic acids such as DNA. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
    Type: Application
    Filed: November 11, 2019
    Publication date: February 27, 2020
    Inventors: David R. Cheng, Pratyusha Hunnewell, David A. Scott, Winston X. Yan